Perivascular nerve fibers containing neuro peptide Y (NPY)-like immunoreactivity were identified around cerebral blood vessels of human, cat, guinea pig, rat, and mouse. The major cerebral arteries were in vested by dense plexuses; veins, small arteries, and arte rioles were accompanied by few fibers. Removal of the superior cervical ganglion resulted in a reduction of NPY -like material in pial vessels and dura mater. Pre treatment with 6-hydroxydopamine or reserpine reduced the number of visible NPY fibers and the concentration of NPY in rat cerebral vessels. Sequential immuno staining with antibodies toward dopamine-�-hydroxylase (DBH) (an enzyme involved in the synthesis of noradren aline) and NPY revealed an identical localization of DBH and NPY in nerve cell bodies in the superior cervical gan glion and in perivascular fibers of pial blood vessels, sug-Cerebral blood vessels are supplied by perivas cular nerve fibers containing acetylcholine, mono amines [noradrenaline and 5-hydroxytryptamine (5-HT)], and a number of polypeptides [vasoactive intestinal peptide, substance P, calcitonin gene-re lated peptide (CGRP), inter alia] (McCulloch, 1984; Edvinsson, 1985b). Although intracerebral peri karya in the neocortex and lower brainstem may be the origin of some cerebrovascular nerve fibers (Eckenstein and Baughman, 1984; Edvinsson et aI., 1983a; Kapadia and de Lanerolle, 1984) , neuroana-
gesting their coexistence. Administration of NPY in vitro resulted in concentration-dependent contractions that were not modified by a sympathectomy. The contractions induced by noradrenaline, 5-hydroxytryptamine, and prostaglandin F2a and the dilator responses to calcitonin gene-related peptide were not modified by NPY in rat cerebral arteries. However, the constrictor response to NPY was reduced by 70% in the presence of the calcium entry blocker nifedipine, and abolished following incuba tion in a calcium-free buffer. These data suggest an inter action of NPY at a postsynaptic site, which for induction of contraction may open calcium channels in the sarco lemma of cerebral arteries. Key Words: Cerebral blood vessels-Immunocytochemistry -In vitro pharma cology-Neuropeptide Y -Radioimmunoassay. tomical studies using anterograde and retrograde tracing (Mayberg et aI., 1984; Arab et aI., 1985) have emphasized the importance of the trigeminal and superior cervical ganglia as the major sources of cerebrovascular nerve fibers. Until 1983 the sole neurotransmitter that was considered to be present in sympathetic nerve fibers was noradrenaline. The chemical discovery of a peptide with an N-terminal tyrosine [neuropeptide Y (NPY)] (Tatemoto, 1982) and the identification of NPY in apparently sympa thetic nerve fibers around cerebral vessels (Ed vinsson et aI., 1983b ) stimulated renewed research interest in sympathetic mechanisms in the cerebral circulation and at many other sites in the body. In the present study we have examined the distribu tion of NPY -containing fibers in various portions of the cerebral circulation and determined the amount of NPY present in pial vessels, dura mater, and choroid plexus in humans and in the four most widely employed experimental animals. In addi-tion, the vasomotor effects of NPY on cerebral blood vessels in these five species have been exam ined and compared.
EXPERIMENTAL PROCEDURES Immunocytochemistry
Specimens were obtained from 10 cats, 30 guinea pigs, 15 rats, and 15 mice. The cats were exsanguinated under pentobarbital anesthesia (Nembutal; 30 mg/kg i.p.), and the rodents were killed under diethyl ether anesthesia. Pial arteries from two patients were obtained in conjunc tion with neurosurgical tumor resections. In 2 guinea pigs and 10 rats, the superior cervical ganglion was unilater ally removed during pentobarbital anesthesia 1 week be fore death. Three rats were given 6-hydroxydopamine (6-OHDA) (l00-150 mg/kg i. v.) 72 and 24 h before death. To prevent oxidation, 6-0HDA was mixed with 0.2 mg/ml ascorbic acid.
The superior cervical ganglia and blood vessels from the circle of Willis were immersed in an ice-cold fixative composed of a mixture of 2% formaldehyde and a 15% saturated aqueous picric acid solution buffered to pH 7.2 with 0.1 M phosphate buffer. All tissue specimens were fixed overnight and thoroughly rinsed in Tyrode buffer containing 10% sucrose at 4°C for 48 h. They were frozen on dry ice and sectioned at 10-20 fLm of thickness in a cryostat. In addition, pial vessels from the cerebral con vexities, the base of the brain, pial veins, and sinusoids were fixed in the same solution overnight. They were then immersed in a Tyrode solution containing 10% su crose for 24-48 h, briefly rinsed in a phosphate buffer, and stretched on chrome-alum-subbed microscope slides as whole mounts. Cryostat sections and whole mounts were processed for the immunocytochemical 1"'1\;0. <!. uvervlew OT me neuropepl10e T (I'll I"' T) Innervallon In the circle of Willis of guinea pig. The rostral part of the circle of Willis appears to be more densely supplied with NPY fibers than the caudal part and basilar and vertebral arteries. aca, anterior cerebral artery; mea, middle cerebral artery; pea, posterior cerebral artery; pcom, posterior communi cating artery; sea, superior cerebellar artery; ba, basilar ar tery; va, vertebral artery; scg, superior cervical ganglion. demonstration of NPY using the indirect immunofluores cence method (Coons et aI., 1955) .
In a separate study, sections from the superior cervical ganglia and stretch preparations of cerebral vessels from guinea pig and rat were first stained for dopamine-�-hy droxylase (DBH), examined in a fluorescence micro scope, and photographed. Thereafter they were rinsed thoroughly and treated with potassium permanganate for 20 s for removal of the antibodies (Tramu et aI., 1978) . Sections and whole mounts devoid of immunofluores cence were further processed for the demonstration of NPY immunoreactivity as above. DBH-immunoreactive nerve fibers were demonstrated with a rabbit antiserum against bovine adrenal medullary DBH (Rush and Geffen, 1981) , used in a dilution of 1:400. NPY-con taining nerve fibers were demonstrated with a rabbit anti serum against porcine NPY, used in a dilution of 1:400 (Sundler et aI., 1983) . The site of the antigen-antibody reaction was revealed by fluorescein isothiocyanate-Ia beled goat anti-rabbit immunoglobulin G (DAKO, Co penhagen, Denmark), used in a dilution of I :20. Sections or stretch preparations incubated with NPY antiserum, which previously had been inactivated by the addition of excess antigen (10-100 ILg/ml pure NPY), were used as controls.
The precise chemical identity of the NPY-immunoreac tive material is still unclear. Cross-reactivity with other, so far unknown, peptides containing amino acid se quences recognized by the NPY antiserum cannot be ex cluded. For brevity the NPY-immunoreactive fibers are referred to as "NPY fibers" in the text.
Radioimmunoassay
HPLC separation was performed on pial vessels, choroid plexus, and dura mater from the various mammals used for immunocytochemistry. Human mate rial was obtained at autopsy 1-2 days post mortem. In addition, seven rabbits were killed by intravenous injec tion of air and the tissues collected. Four rats were given reserpine (l mg/kg i.p.) 24 h before death. The specimens were freeze-dried, and the extract was reconstituted in water and analyzed on a C IS fL-bondapak reverse-phase HPLC column using a Waters series 600 HPLC with a fraction volume of 2 ml and a gradient from 5 to 65% acetonitrile in 10 mM ammonium acetate buffer (pH 4.5). The result obtained was compared with that of the elution position of pure porcine NPY. The radioimmunoassay curve of NPY material extracted from cat pial vessels was diluted (1:2 to 1: 16) along with the standard curve of pure porcine NPY (Edvinsson et aI., 1983b) . Over the midrange of the radioimmunoassay, the material dilutes generally in parallel with the NPY standard curve. For further methodological details, see Emson et aJ. (1984) .
Response of isolated cerebral arteries
Cerebral arteries from 8 cats, 7 rabbits, 7 guinea pigs, and 20 rats were tested for vasomotor reactivity using a sensitive in vitro method (H6gestatt et aI., 1983) . The ce rebral arteries were dissected free and placed in a cold buffer solution aerated with 5% CO2 in O2, In the rats the whole brain and brains team were immediately removed and placed in cold calcium-free Krebs solution [no eth ylene glycol bis(�-aminoethyl ether) N, N '-tetraacetic acid (EGTA)]. The rat middle cerebral and basilar arteries were dissected under the microscope and stored for 1-15 h in the Krebs solution. Pial arterial segments were also obtained from three patients in conjunction with neuro surgical tumor resections and treated as above. Vessel segments, 2-3 mm long, were mounted between two L shaped metal prongs in 2.5-ml mantled tissue baths kept at + 3TC for recording of circular vasomotor activity. Isometric tension was measured with Grass force-dis placement transducers and recorded on a Grass poly graph. The segments were given a passive load of 4 mN (except for the rat vessels, which received 2 mN), and allowed to attain a steady level of tension and to stabilize for 90 min before testing.
The contractile capacity of the vessels was examined by exposure to a buffer solution in which the KCI con centration was 124 mM. After reproducible contractions were obtained, the contractile capacity of various ago nists was tested by either cumulative-or single-dose ap plication. Only one concentration-response curve was obtained with NPY in each vessel segment since prelimi nary tests revealed a tendency to develop tachyphylaxis.
Arterial segments were repeatedly contracted with an appropriate agonist until a reproducible contractile force was achieved. The segments were then contracted by the same agonist after a 2-min incubation with NPY (10 mM). The maximum contractile effort of the arterial segments was determined by contraction with 124 mM K + Krebs solution. Responses are given as a percentage of this K + induced contraction.
With CGRP-induced relaxation (in rats), arterial seg ments were first contracted with 5-HT (10 f-LM); and after a steady level of contraction was obtained, CGRP was added cumulatively. After repeated washings and a 60min recovery time, NPY (10 nM) was added and 2 min later the CGRP concentration response was again deter mined. The CGRP relaxation is reported as percentage reduction from the contractile response before CGRP ex posure.
Contractions in calcium-free medium were performed after incubation for 10 min in calcium-free Krebs solution with 0. 1 mM EGTA. Contractions in the presence of the calcium channel blocker nifedipine were done after a 10min incubation with the calcium antagonist.
Solutions and Drugs
The following solutions were used: (a) standard Krebs solution (mM): NaCI 119, KCl 4. 6, CaClz 1. 5, MgClz 1. 2, NaHC03 15, NaH2P04 1. 2, glucose 6.0. (b) 124 mM K + Krebs solution: as above, substituting equimolar amounts of KCl for NaCI. (c) Ca 2 + -free standard Krebs:
as above, substituting 0. 1 mM EGTA (Sigma) for CaClz. 1987 FIG. 3. Whole-mount preparation from the dura mater of cat, illus trating a network of neuropeptide Y (NPY)-immunofluorescent nerve fibers. In other regions only occa sional NPY fibers are seen. x 175.
Analytical-grade chemicals and double-distilled water were used for preparing all solutions.
The following drugs were used: (± )-noradrenaline HCI (Sigma, U.S.A.), 5-HT (Sigma), prostaglandin F2 u (Amoglandin; Astra, Sweden), nifedipine (Bayer, ER. G. ), NPY (Peninsula, U. S. A.), CGRP (CRB, U.K.), 6-0HDA (Sigma), and reserpine (Serpasil; Ciba-Geigy, Switzerland). Nifedipine was provided in ampules (0.1 mg/m!) dis solved in ethanol (150 mg/m!) and polyethylene glycol (150 mg/m!) in water. Nifedipine was protected from light until use. All drugs were diluted to appropriate concen trations with 0. 9% NaCI with I mM ascorbic acid. The concentrations of the agents are given as final concentra tions in the baths.
RESULTS

Distribution of NPY immunoreactivity
NPY -immunoreactive nerve fibers were ob served in brain vessels from humans, cats, guinea pigs, rats, and mice. In all of the experimental an imals, the number of NPY fibers varied according to the diameter of the vessels (Fig. 1 ). In the walls of large-size arteries belonging to the circle of Willis, numerous NPY fibers were visualized, whereas smaller branches of these arteries had fewer fibers. The fibers were seen to run in the ad ventitial layer, sometimes approaching the media layer. The highest density of NPY fibers was found in vessels belonging to the rostral part of the circle of Willis (Fig. 2) . Pial arterioles and veins on the cerebral cortex had a moderate supply of NPY fibers (Fig. 1) . In some sections the NPY fibers could be seen to follow the vessels as they pene-trated into the cerebral parenchyma. Large cerebral veins and sinusoids were also encircled with NPY fibers. Few fibers, usually adjacent to vessels, were observed in the dura mater ( Fig. 3 ). Only occa sional NPY fibers were seen in the choroid plexuses.
The superior cervical ganglia contained nu merous NPY -immunoreactive nerve cell bodies and nerve fibers. Following removal of the superior cervical ganglion, there was a noticeable reduction in the number of NPY fibers in the ipsilateral cere- bral vessels (Fig. 4 ). This reduction in immunoreac tivity paralleled that noted in the radioimmuno assay measurements (see below). A marked reduc tion in the number of visible NPY fibers was found following the administration of 6-0RDA ( Fig. 4 ) and reserpine.
Coexistence of NPY immunoreactivity with that of DBR Sequential immunostaining with antisera against DBR and NPY revealed that the distribution of the two immunoreactive products matched precisely both in nerve cell bodies of the superior cervical ganglion and in nerve fibers around the pial vessels of guinea pig (Fig. 5 ). The identical topographies of NPY and DBH are indicative of their coexistence. 1987 Radioimmunoassay of NPY Analysis of NPY-like immunoreactivity in acid extracts from various experimental animals (Table  1) and humans (Table 2) revealed that the immuno reactive material could be diluted in parallel in the Values are means ± SEM, n = no. of animals examined.
radioimmunoassay with authentic porcine NPY. High concentrations of NPY-like immunoreactivity were noted in pial vessels, whereas low concentra tions or no detectable amounts were noted in the dura mater and the choroid plexus (Tables 1 and 2) . These findings are in excellent accord with the im munocytochemical observations. Surgical and chemical (reserpine treatment) sympathectomy sig nificantly reduced the concentration of NPY in pial vessels from rats by 40 and 65%, respectively. In dura mater the reduction in NPY concentration was more pronounced: Reductions by 81 and 73% were noted with surgical and chemical sympathectomy, respectively ( Table 3) .
Contractile responses in vitro
NPY regularly induced contractions of isolated cerebral arterial segments from the species investi gated. Within the concentration range examined, maximum contraction induced by NPY varied be tween 0.4 (rabbit) and 5. 4 (cat) mN ( Table 4 ). The mean concentration eliciting half-maximal contrac tion (EC50) could in most species not be calculated since the maximum contraction (E m ax) was not ob tained in all species owing to the limited supply of NPY; therefore, the maximum contractions could not be defined absolutely. However, it was 13 ± 15 nM in the cat middle cerebral artery, � 1 0 nM in human pial arteries and rat cerebral arteries, and �50-100 nM in the other species (Fig. 6A ). There Tissue was obtained at autopsy 1-2 days post mortem. Values are means ± SEM, n = no. of specimens examined. Values are means ± SEM, n = no. of animals.
By Student's t test: ap < 0.05; bp < 0.01; cp < 0.001.
was no significant change in the vasomotor reac tivity to NPY of isolated rat basilar or middle cere bral arteries 1 week after sympathectomy (Fig. 6B) .
The ability of NPY to potentiate various vaso constrictors was tested in the rat middle cerebral and basilar arteries. The basal arterial tension was minimally affected by the presence of NPY (10 nM) in the tissue bath. Exposure of cerebral vessels to NPY (10 nM) for 2 min did not affect the sensitivity (EC50) or the maximum contraction (E m ax) of nor adrenaline, 5-HT, or prostaglandin F2a (Fig. 7) . The effect of prostaglandin F2a on contractions in the basilar artery displayed marked interanimal vari ability, with contractions occurring in basilar ar teries from some animals but not in others. How ever, in basilar arteries that responded to prosta glandin F2a, the contractions were not affected by NPY (10 nM) pretreatment.
The effects of NPY (10 nM) on CGRP-induced relaxation in arteries pre contracted by 5-HT 00 f.LM) were tested in both the middle cerebral and the basilar arteries of rats ( Fig. 8) . While NPY had no effect on the CGRP-induced relaxation in the middle cerebral artery, it caused a modest reduc tion in the amount of relaxation in the basilar ar tery.
The contractile effects of NPY on cerebral ar teries were markedly less sustained than those elic ited by noradrenaline (1 mM) and potassium (124 mM). Five minutes after the addition of noradrena line or potassium to the tissue bath, the contraction was only 10% less than the initial maximal contrac tion. In contrast, 5 min after the addition of NPY to the tissue bath, the contraction was 82% lower than the initial maximal contraction produced by the peptides (Fig. 9) .
The maximum contractile response to NPY (70 nM) in the middle cerebral artery was reduced by 70% in the presence of nifedipine (0.3 f.LM) (Fig.  10) . Incubation of the vessels for 10 min in a cal- Values are means ± SEM. The maximum contraction elicited by 124 mM K+ (within parentheses) was taken as 100% and the neuropeptide Y effects given as a percentage of this. 
DISCUSSION
NPY is one of the most abundant and most widely distributed of the peptides in the nervous system. It is present in high concentrations in neu rons of the central nervous system, in sympathetic ganglia, and in nerve fibers that innervate smooth muscle and glandular tissue throughout the body (Emson and De Quidt, 1984) . In many sites in the central nervous system and in the periphery, NPY coexists with noradrenaline (Lundberg et aI., 1984; Fried et aI., 1985) . Over the last few years, the in nervation of cerebral blood vessels by nerve fibers containing NPY has been described in a small number of species, using either immunocytochem istry (Edvinsson et aI., 1983b (Edvinsson et aI., , 1984b Alafaci et aI., FIG. 6. (Continued) 1985) or radioimmunoassay (Allen et aI., 1984) . In every species examined (human, cat, rabbit, guinea pig, gerbil, and rat), the cerebrovascular bed is sup plied with nerve fibers containing NPY. There is good agreement between the immunocytochemical and radioimmunological data. High concentrations of NPY are found in cerebral vessels, low levels in dura mater, and, with the exception of the rabbit, undetectable amounts in the choroid plexus. The NPY fibers form a typical ground plexus that re sembles that of the noradrenaline-containing sym pathetic innervation of the cerebrovascular bed (Nielsen and Owman, 1967) . The present investiga tion in the cerebrovascular bed and other studies elsewhere in the body have indicated that DBH and NPY coexist in nerve cell bodies and in perivas cular nerve fibers (Ekblad et aI., 1984; Uddman et aI. , 1985) . Furthermore, both the number of visible fibers and the concentrations of noradrenaline and NPY are reduced after surgical or chemical sym pathectomy, adding further support to the compel ling evidence of the co-localization of NPY and noradrenaline.
There are marked interspecies differences in the concentrations of NPY that are present in pial vessels. The highest levels of NPY are found in ce rebral vessels from the rabbit and guinea pig (�75 pmol!g), intermediate levels in the cat and rat (�25 pmol!g), and least in human pial vessels (�3 pmoll g). The interspecies hierarchy for the levels of NPY in pial vessels is distinct from that for cerebrovas cular levels of 5-HT (Scatton et aI., 1985) , vasoac tive intestinal peptide (Edvinsson et aI., 1980) , sub-J Cereb Blood Flow Metab. Vol. 7. No.1. 1987 stance P (Duckles and Buck, 1982; Edvinsson et aI., 1983c) , and acetylcholine (Duckles, 1981) , al though the levels in human pial vessels of almost all neurotransmitters are less than in other species. The interspecies differences in cerebrovascular NPY levels parallel, at least in general terms, those for noradrenaline; e.g., the levels of noradrenaline in the pial vessels of the rat and cat are similar, and those in the rabbit threefold greater (Edvinsson et aI., 1972; Duckles, 1981) .
Previous investigations of the endogenous NPY levels in human cerebral vessels have yielded mark edly different results, with estimates ranging from �2 pmol/g (Allen et aI., 1984) to �50 pmol/g (Lund- berg et aI., 1983). Our data in humans are in general accord with these results. It should also be noted that the cerebrovascular levels of NPY appear to be age dependent (Edvinsson et aI., 1985a) . There is no difference, at least in humans, in the levels of NPY around different intracranial arteries (see also Allen et aI., 1984) . However, lesser amounts of NPY are present in extracranial arteries such as the internal carotid artery than in the intracranial ar teries branching from this vessel. The vasomotor effects of NPY have been sys tematically examined, hitherto only in feline cere bral vessels, in which this peptide causes a pro nounced concentration-dependent contraction of cerebral arteries both in vitro and in situ (Ed vinsson et aI., 1984b; Edvinsson, 1985a) . In all ce rebral arteries for all species studied, NPY is able to elicit contractile responses; although in the vessels from the rabbit and guinea pig, contractile responses are observed only with high concentra tions of NPY (in excess of 0. 1 /-LM). The maximum contraction produced by NPY is generally compa rable with or slightly greater than the maximum re sponse that has been observed previously with nor- Pretreatment of vessel segments for 10 min in a calcium-free medium with 0.1 mM ethyleneglycol bis(aminoethylether) tetraacetate. NPY (70 nM) failed to elicit a significant con traction.
adrenaline (Skiirby et aI. , 1983) . Sympathectomy did not modify the NPY -induced contraction in rat cerebral arteries. The <X2-and �-adrenoceptor an tagonists rauwolscine and propranolol, respec tively, and the 5-HT antagonist ketanserin did not modify the NPY -induced contractions in cat cere bral vessels, indicating that the action of NPY is not related to activation of these amine receptors (Edvinsson et aI., 1983b) . In contrast to the consis tent direct contractile effects of NPY on the cere bral vasculature in vitro and in situ (Edvinsson et aI., 1983b (Edvinsson et aI., , 1984b Edvinsson, 1985a; present study) , the influence of NPY on cerebral tissue per fusion in vivo is less well defined. It appears im probable that intravascular NPY would markedly influence cerebral blood flow because blood-brain barrier mechanisms would prevent the access of the polypeptide to its receptors on arteriolar resis tance vessels (see Allen et aI., 1984; Tuor et aI., 1985) . However, the intracerebral stereotaxic mi croapplication of NPY is conscious rats elicits a marked reduction in local cerebral blood flow, which is unrelated to any change in local cerebral glucose utilization (Thor et aI., 1987) . ) ro 20
In peripheral arteries of both humans and labora tory animals, NPY potentiates contractions in duced by noradrenaline, histamine, and transmural nerve stimulation (Edvinsson et aI. , 1984a (Edvinsson et aI. , , 1985b Ekblad et aI., 1984) . This action of NPY in blood vessels may involve at least two different prin ciples: firstly, stimulation of a postulated receptor site that causes the influx of extracellular calcium to produce intense contraction (Edvinsson, 1985a) ; secondly, potentiation of amine-induced contractions (Edvinsson et aI., 1984a (Edvinsson et aI., , 1985b Ekblad et aI. , 1984) . The potentiating effect, which is seen in pe ripheral arteries, may occur via inhibition of ade nylate cyclase in the smooth muscle cells (Fred holm et al., 1985) , or it may involve the N a + , K + AT Pase system in the sarcolemma (Wahlestedt et aI. , 1985) . In cerebral vessels of the rat, potentia tion of neither constrictor nor dilator agonists was observed. A presynaptic effect of NPY can be ex cluded by the fact that sympathectomy did not modify the NPY-induced contraction in rat cerebral arteries. Furthermore, studies on the release of 3H_ labeled noradrenaline from cat cerebral vessels (Edvinsson and Skarby, 1984) and rabbit peripheral arteries (Ekblad et aI., 1984) in conjunction with transmural nerve stimulation did not reveal any ef fect of NPY in concentrations that were observed to induce constriction. In contrast, a marked re duction (40%) in the fractional release of 3H -labeled noradrenaline has been shown in the rat portal vein (DahlOf et aI., 1985) ; however, this response rather suggests a depressive effect of NPY on vascular smooth muscle tone. The elimination of the contractile response to NPY in a calcium-free medium demonstrates the need for extracellular calcium and the lack of mobi lization of calcium from intracellular pools. Inter estingly, the NPY contractions were not completely blocked by high concentrations of nifedipine (0. 3 fLM), a concentration that caused a similar reduc tion of potassium-induced contractions in rat bas ilar arteries (HogesHitt and Andersson, 1984) . Fur thermore, several of the calcium entry blockers, e.g., nimodipine, nifedipine, and verapamil, have been found to cause an immediate relaxation of NPY -induced contractions (Edvinsson et aI. , 1983b) . In the absence of extracellular calcium, the administration of NPY results only in weak con centrations, and the addition of calcium in in creasing concentrations (0.01-4 mM) to feline middle cerebral arteries results in contractions that can be prevented by the calcium entry blocker ni modipine (Edvinsson, 1985a) . 
